Innovita Biological Technology Co., Ltd. (together with its subsidiaries, collectively referred to as “INNOVITA”) is a biotechnology company specialized in R&D, manufacturing and sales of POCT in vitro diagnostic products, under which the subsidiaries including Innovita (Tangshan) Biological Technology Co., Ltd. have been established. 

Founded in 2006, Innovita Biological has been in possession of antigen antibody preparation, virus culture, colloidal gold, ELISA, fluorescent tomography, immunofluorescence and other technology platforms. Moreover, it has undertaken the national 863 project – National Special Research on Infectious Diseases and many public health projects. Furthermore, it also has over ten national innovation patents. INNOVITA has established Beijing R&D Center and Hebei Qian'an Manufacturing Base, and provided large-scale clean workshops. On this basis, it has built the production lines such as colloidal gold, ELISA, fluorescent tomography, PCR and immunofluorescence, and further passed CE and ISO13485 quality certification 

Current products of Innovita Biological has covered multiple fields of testing such as respiratory tract series, child-bearing and child-rearing series, hepatitis series, reproductive series, cardiovascular series, and renal function series, etc. In terms of the sales channels, its products are sold in all provinces and regions across China, and exported to the overseas regions including Southeast Asia, the Middle East, Africa, Latin America, and EU  In compliance with its user-centered business idea, INNOVITA provides more accurate and convenient products and services for its users, and adheres to the idea that the needs of users are the pursuits of INNOVITA.